These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 16224383

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Hydroxyurea in essential thrombocytosis.
    Van Genderen PJ, Michiels JJ.
    N Engl J Med; 1995 Sep 21; 333(12):802-3. PubMed ID: 7643898
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Neurologic manifestations of essential thrombocythemia.
    Ann Intern Med; 1984 Feb 21; 100(2):316-7. PubMed ID: 6691684
    [No Abstract] [Full Text] [Related]

  • 46. Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders.
    Quintás-Cardama A, Kantarjian HM, Giles F, Verstovsek S.
    Semin Thromb Hemost; 2006 Jun 21; 32(4 Pt 2):409-16. PubMed ID: 16810616
    [Abstract] [Full Text] [Related]

  • 47. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
    Ito E, Muro Y, Shibata A, Sugiura K, Akiyama M.
    Dermatol Online J; 2014 Aug 17; 20(8):. PubMed ID: 25148281
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a].
    Tichelli A, Gratwohl A, Delacrétaz F, Dazzi H, Stebler C, Wernli M, Holdener EE, Nissen C, Speck B.
    Schweiz Med Wochenschr; 1989 Sep 30; 119(39):1347-52. PubMed ID: 2799342
    [Abstract] [Full Text] [Related]

  • 50. Severe hypersensitivity pneumonitis associated with anagrelide.
    Raghavan M, Mazer MA, Brink DJ.
    Ann Pharmacother; 2003 Sep 30; 37(9):1228-31. PubMed ID: 12921504
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].
    Gotić M, Cvetković M, Bozanović T, Cemerikić V.
    Srp Arh Celok Lek; 2001 Sep 30; 129(11-12):304-8. PubMed ID: 11928616
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Inflammatory livedo and idiopathic thrombocythemia. Remarkable therapeutic action of hydroxyurea].
    Lèques B, Texier L, Verdaguer J.
    Bull Soc Fr Dermatol Syphiligr; 1967 Sep 30; 74(4):545-8. PubMed ID: 5585217
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
    Alvarado Y, Cortes J, Verstovsek S, Thomas D, Faderl S, Estrov Z, Kantarjian H, Giles FJ.
    Cancer Chemother Pharmacol; 2003 Jan 30; 51(1):81-6. PubMed ID: 12497210
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Thrombocytosis associated with a myeloproliferative disorder in a dog.
    Degen MA, Feldman BF, Turrel JM, Goding B, Kitchell B, Mandell CP.
    J Am Vet Med Assoc; 1989 May 15; 194(10):1457-9. PubMed ID: 2722642
    [Abstract] [Full Text] [Related]

  • 60. Childhood essential thrombocytosis.
    Papageorgiou T, Theodoridou A, Kourti M, Nikolaidou S, Athanassiadou F, Kaloutsi V.
    Pediatr Blood Cancer; 2006 Dec 15; 47(7):970-1. PubMed ID: 16628554
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.